ArticleACS omega2025
Incorporating Real World Experiences in an Undergraduate Biochemistry Laboratory CourseDetection of Gluten in Food and Beverages Using an Enzyme-Linked Immunosorbent Assay.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Celiac disease (CD), an autoimmune disease affecting 1% of the global population, is caused by the consumption of gluten. Gluten is a storage protein that is found in wheat, rye, and barley. The addition of gluten to food products imparts unique viscous and elastic characteristics in foods such as bread. The only recommended treatment for celiac disease is a gluten-free diet. The consumption of gluten-free labeled food products reduces the risk of an autoimmune response and other symptoms associated with celiac disease, including anemia, dermatitis herpetiformia, osteoporosis, muscle weakness, ataxia, and coagulopathy. The Codex Alimentarius and Food and Drug Administration (FDA) state that gluten-free foods must limit gluten content to 20 ppm. Using an enzyme-linked immunosorbent assay (ELISA), quantitative studies can be performed to detect the concentration of gluten present in gluten-free food products. This work uses a direct ELISA to quantify the amount of antigen (gluten) present by measuring absorbance in gluten-containing and gluten-free food products. A color gradient was observed based on the increasing concentration of gluten present in each gluten standard. Multiple substrates (
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.